Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications

J Zielonka, J Joseph, A Sikora, M Hardy… - Chemical …, 2017 - ACS Publications
Mitochondria are recognized as one of the most important targets for new drug design in
cancer, cardiovascular, and neurological diseases. Currently, the most effective way to …

Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers

K Chen, P Lu, NM Beeraka, OA Sukocheva… - Seminars in cancer …, 2022 - Elsevier
Epigenetic regulation of mitochondrial DNA (mtDNA) is an emerging and fast-develo**
field of research. Compared to regulation of nucler DNA, mechanisms of mtDNA epigenetic …

Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release

DB Zorov, M Juhaszova, SJ Sollott - Physiological reviews, 2014 - journals.physiology.org
Byproducts of normal mitochondrial metabolism and homeostasis include the buildup of
potentially damaging levels of reactive oxygen species (ROS), Ca2+, etc., which must be …

Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours

S Missiroli, M Perrone, I Genovese, P Pinton… - EBioMedicine, 2020 - thelancet.com
Mitochondria are dynamic organelles that have essential metabolic activity and are
regarded as signalling hubs with biosynthetic, bioenergetics and signalling functions that …

Mitochondrial complex II: at the crossroads

A Bezawork-Geleta, J Rohlena, L Dong, K Pacak… - Trends in biochemical …, 2017 - cell.com
Mitochondrial complex II (CII), also called succinate dehydrogenase (SDH), is a central
purveyor of the reprogramming of metabolic and respiratory adaptation in response to …

Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells

LF Dong, J Kovarova, M Bajzikova, A Bezawork-Geleta… - elife, 2017 - elifesciences.org
Recently, we showed that generation of tumours in syngeneic mice by cells devoid of
mitochondrial (mt) DNA (ρ0 cells) is linked to the acquisition of the host mtDNA. However …

[HTML][HTML] Mitochondrial pharmacology

RAJ Smith, RC Hartley, HM Cocheme… - Trends in pharmacological …, 2012 - cell.com
Mitochondria are being recognized as key factors in many unexpected areas of biomedical
science. In addition to their well-known roles in oxidative phosphorylation and metabolism, it …

Mitochondria‐targeted antioxidants: a step towards disease treatment

Q Jiang, J Yin, J Chen, X Ma, M Wu… - Oxidative medicine …, 2020 - Wiley Online Library
Mitochondria are the main organelles that produce adenosine 5′‐triphosphate (ATP) and
reactive oxygen species (ROS) in eukaryotic cells and meanwhile susceptible to oxidative …

Regulation of succinate dehydrogenase and role of succinate in cancer

E Dalla Pozza, I Dando, R Pacchiana, E Liboi… - Seminars in cell & …, 2020 - Elsevier
Succinate dehydrogenase (SDH) has been classically considered a mitochondrial enzyme
with the unique property to participate in both the citric acid cycle and the electron transport …

Mitocans revisited: mitochondrial targeting as efficient anti-cancer therapy

L Dong, V Gopalan, O Holland, J Neuzil - International journal of …, 2020 - mdpi.com
Mitochondria are essential cellular organelles, controlling multiple signalling pathways
critical for cell survival and cell death. Increasing evidence suggests that mitochondrial …